Great news! Keythera Biopharmaceuticals has emerged as the champion in the final of the 10ᵗʰ China Innovation and Entrepreneurship Competition.

Technological innovation leads to great achievements! On December 28, 2021, the national final of the 10ᵗʰ China Innovation and Entrepreneurship Competition kicked off in Guangzhou High-tech Zone. Since the start of the 10^ᵗʰ China Innovation and Entrepreneurship Competition, a total of 33,289 companies have registered to participate. After selection in 37 regional competitions, 1,500 companies advanced to the national competition, and from them, the "Top 50 Innovations and Entrepreneurship" were selected to enter the national final. Among the Top 50, Keythera Biopharmaceuticals, after fierce competition in the final this afternoon, ultimately emerged as the first-place winner in the initial startup group of the national final of the 10^ᵗʰ China Innovation and Entrepreneurship Competition!

This is another honor for Keythera Biopharmaceuticals after winning the "Excellent Project Award" in the field competition of the first National Subversive Technology Innovation Competition (Suzhou) on December 22, 2021.

Since its establishment, Keythera Biopharmaceuticals has consistently focused on technological innovation as a key breakthrough. It has closely aligned with the national strategy of independent innovation and has established a pipeline of new drug products targeting tumors and autoimmune diseases using its independently developed high-throughput drug screening platform. Keythera Biopharmaceuticals expresses gratitude for the recognition of the company's team, products, and technology by the judges.

Keythera Biopharmaceuticals firmly believes that in the favorable atmosphere for innovation and entrepreneurship created by the country and with the trust and support of investment institutions, it will be able to develop innovative and differentiated products to meet the needs of patients and contribute to society!

Back to List